Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
319.43
-0.99 (-0.31%)
At close: Jul 7, 2026, 4:00 PM EDT
319.43
0.00 (0.00%)
After-hours: Jul 7, 2026, 4:27 PM EDT
Ligand Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Ligand Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $277.6. The average 1-year stock price forecast is 13.10% lower than the current stock price, while the lowest is $247 (-22.67%) and the highest is $330 (+3.31%).
Price Target: $277.6 (-13.10%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 2, 2026.
Analyst Ratings
The average analyst rating for Ligand Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 1, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $266 | Buy | Maintains | $266 | -16.73% | Jun 2, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $262 | Buy | Reiterates | $262 | -17.98% | May 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $289 | Buy | Reiterates | $289 | -9.53% | May 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $230 → $255 | Buy | Reiterates | $230 → $255 | -20.17% | Apr 27, 2026 |
Financial Forecast
Revenue This Year
287.66M
from 268.09M
Increased by 7.30%
Revenue Next Year
370.56M
from 287.66M
Increased by 28.82%
EPS This Year
9.10
from 8.13
Increased by 11.95%
EPS Next Year
11.32
from 9.10
Increased by 24.34%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 309.7M | ||
| Avg | 287.7M | ||
| Low | 278.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.5% | ||
| Avg | 7.3% | ||
| Low | 4.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.67 | ||
| Avg | 9.10 | ||
| Low | 8.79 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 18.9% | ||
| Avg | 11.9% | ||
| Low | 8.1% |